Prevention, screening, and vaccination are vital for managing infection risk during pregnancy due to altered maternal immunity.
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS) ...
Gut microbes may play a key role in training a mother's immune system to adapt to the developing fetus during pregnancy, ...
Ninety-nine percent of global newborn deaths occur in low- and middle-income countries (LMICs), where pregnant women often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results